Overview

Hippocratic AI develops advanced language models specifically designed for healthcare applications. Their models are tailored to improve healthcare access, equity, and outcomes while ensuring safety and reliability for non-clinical tasks. The company has created a model that has outperformed GPT-4 in 105 out of 114 healthcare exams, showcasing its accuracy. Hippocratic AI serves hospitals, clinics, and healthcare providers, offering AI solutions to enhance patient care and operational efficiency. Unlike general-purpose models, Hippocratic AI's products are pre-trained on evidence-based healthcare content and validated through a process involving healthcare professionals. The company generates revenue through licensing its models, forming partnerships with healthcare organizations, and potentially offering subscription services for ongoing support. The goal of Hippocratic AI is to lead in the healthcare AI sector by providing safe, effective, and compassionate AI interactions.

Simplify's Take

What believers are saying

• Raised $141M in Series B, valuing the company at $1.64 billion.
• Launched AI Agent App Store, enhancing clinician-driven healthcare AI development.
• Strong market traction with diverse healthcare clients and positive patient response.

What critics are saying

• Faces competition from Qventus in patient flow automation technology.
• High valuation may lead to increased scrutiny from investors and stakeholders.
• CEO's involvement in other ventures could divert focus from core objectives.

What makes Hippocratic AI unique

• Hippocratic AI's LLMs outperform GPT-4 in 105 of 114 healthcare exams.
• The company focuses on non-clinical healthcare tasks, ensuring safety and reliability.
• Hippocratic AI uses Reinforcement Learning with Human Feedback for model validation.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$268.5M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:

SV AngelKleiner PerkinsGeneral CatalystAndreessen Horowitz

Notable Investors:

SV AngelKleiner PerkinsGeneral CatalystAndreessen Horowitz

$141,000,000

Series B

Jan 2025

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$45M

$65M

$100M

$141M

View all funding stages